Details of the Drug

General Information of Drug (ID: DME0ONY)

Drug Name
IGN002
Indication
Disease Entry ICD 11 Status REF
Non-hodgkin lymphoma 2B33.5 Phase 1 [1]
Cross-matching ID
TTD ID
D01RQP

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)